Cradle is a biotechnology company founded in 2021, based in Delft, Netherlands, with additional offices in Amsterdam, Zurich, Boston, and California. The company specializes in AI-powered protein engineering, focusing on the design and development of high-performing proteins. With a team of 51-200 professionals from diverse backgrounds, Cradle combines expertise in biology, machine learning, and engineering to enhance protein engineering processes. Cradle's SaaS platform utilizes AI and machine learning to generate optimized protein variants quickly, improving properties such as activity, binding, and stability. This technology reduces experimental cycles and accelerates the development of therapeutics, agricultural solutions, and materials across various industries. The company emphasizes client ownership of intellectual property without royalties or revenue sharing. Cradle serves notable clients, including Johnson & Johnson and Novozymes, and has raised $103 million in funding to expand its capabilities and reach more laboratories globally.